Whitehawk Therapeutics, Inc.
WHWK
$1.57
$0.031.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.98M | 25.07M | 23.82M | 23.84M | 24.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.98M | 25.07M | 23.82M | 23.84M | 24.35M |
| Cost of Revenue | 54.05M | 52.61M | 54.40M | 54.50M | 51.74M |
| Gross Profit | -28.07M | -27.54M | -30.58M | -30.66M | -27.38M |
| SG&A Expenses | 36.75M | 36.04M | 40.08M | 43.96M | 44.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 90.80M | 88.66M | 94.48M | 98.46M | 96.29M |
| Operating Income | -64.82M | -63.59M | -70.66M | -74.62M | -71.93M |
| Income Before Tax | -63.69M | -61.69M | -65.44M | -68.83M | -65.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.69 | -61.69 | -65.44 | -68.83 | -65.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.69M | -61.69M | -65.44M | -68.83M | -65.77M |
| EBIT | -64.82M | -63.59M | -70.66M | -74.62M | -71.93M |
| EBITDA | -64.63M | -63.40M | -70.47M | -74.44M | -71.76M |
| EPS Basic | -2.36 | -2.29 | -2.43 | -2.55 | -2.44 |
| Normalized Basic EPS | -1.41 | -1.37 | -1.52 | -1.60 | -1.53 |
| EPS Diluted | -2.36 | -2.29 | -2.43 | -2.55 | -2.44 |
| Normalized Diluted EPS | -1.41 | -1.37 | -1.52 | -1.60 | -1.53 |
| Average Basic Shares Outstanding | 108.12M | 108.00M | 107.90M | 107.77M | 107.65M |
| Average Diluted Shares Outstanding | 108.12M | 108.00M | 107.90M | 107.77M | 107.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |